Efficacy of Prophylactic Agents in Preventing Adhesive Small Bowel Obstruction: A Systematic Review and Meta-Analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Intra-peritoneal adhesion prophylactic agents significantly reduced early and late small bowel obstruction (SBO) rates after abdominal surgery. Efficacy varied by agent, with Guardix® showing effectiveness in reducing late SBOs. Adverse events were comparable between groups.
Area Of Science
- Gastroenterology and Surgical Innovation
- Adhesion Prevention and Small Bowel Obstruction Management
Background
- Adhesive disease is a common complication following abdominal surgery, frequently leading to small bowel obstructions (SBOs).
- The effectiveness of intra-peritoneal adhesion prophylactic agents in reducing SBO rates remains a critical clinical question.
Purpose Of The Study
- To evaluate the impact of intra-peritoneal adhesion prophylactic agents on reducing early and late small bowel obstruction (SBO) rates in adult patients.
- To compare the efficacy of different adhesion prophylactic agents and assess their effect on adverse event rates.
Main Methods
- A systematic literature search was conducted across major databases (PubMed, Embase, Cochrane, Web of Science) for relevant English-language studies published between 2000 and 2024.
- Included studies focused on SBOs following the use of intra-peritoneal adhesion prophylactic agents, with meta-analyses performed on 12 randomized controlled trials and 14 observational studies.
- Outcomes assessed included early (<30 days) and late (>30 days) SBO rates, as well as adverse events such as anastomotic leak, intra-abdominal abscess, and wound infection.
Main Results
- The use of intra-peritoneal adhesion prophylactic agents was associated with a significant reduction in both early (1.1% vs 2.9%) and late (7.6% vs 9.9%) SBO rates.
- Sub-analysis indicated that Guardix® effectively reduced late SBO rates, whereas Seprafilm did not show a significant effect.
- Rates of adverse events were comparable between patients who received prophylactic agents and those who did not.
Conclusions
- Intra-peritoneal adhesion prophylactic agents demonstrate efficacy in reducing small bowel obstruction rates post-abdominal surgery, though effectiveness varies among agents.
- Guardix® emerged as a potentially more effective agent for preventing late SBOs compared to Seprafilm.
- Further research is warranted to optimize clinical applications and evaluate the long-term outcomes associated with these prophylactic agents.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Strictureplasty
Proctocolectomy or total colectomy with ileostomy
Restorative proctocolectomy with Ileal pouch-anal anastomosis
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...